These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 18371028

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mechanism(s) of FIV vaccine protection.
    Pu R, Tellier MC, Yamamoto JK.
    Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
    [Abstract] [Full Text] [Related]

  • 24. Duration of antibody response following vaccination against feline immunodeficiency virus.
    Westman ME, Malik R, Hall E, Harris M, Hosie MJ, Norris JM.
    J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
    [Abstract] [Full Text] [Related]

  • 25. Effect of dual-subtype vaccine against feline immunodeficiency virus infection.
    Hohdatsu T, Okada S, Motokawa K, Aizawa C, Yamamoto JK, Koyama H.
    Vet Microbiol; 1997 Nov; 58(2-4):155-65. PubMed ID: 9453127
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Preliminary evaluation of a quantitative polymerase chain reaction assay for diagnosis of feline immunodeficiency virus infection.
    Ammersbach M, Little S, Bienzle D.
    J Feline Med Surg; 2013 Aug; 15(8):725-9. PubMed ID: 23362341
    [Abstract] [Full Text] [Related]

  • 28. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
    Hofmann-Lehmann R, Aubert A, Wolfensberger C, Cronier J, Lutz H.
    Schweiz Arch Tierheilkd; 1994 Aug; 136(10):340-51. PubMed ID: 7801087
    [Abstract] [Full Text] [Related]

  • 29. Effects of passive transfer of immunity on results of diagnostic tests for antibodies against feline immunodeficiency virus in kittens born to vaccinated queens.
    MacDonald K, Levy JK, Tucker SJ, Crawford PC.
    J Am Vet Med Assoc; 2004 Nov 15; 225(10):1554-7. PubMed ID: 15568387
    [Abstract] [Full Text] [Related]

  • 30. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
    Pedersen NC, North TW, Rigg R, Reading C, Higgins J, Leutenegger C, Henderson GL.
    Vet Immunol Immunopathol; 2003 Aug 15; 94(3-4):133-48. PubMed ID: 12909410
    [Abstract] [Full Text] [Related]

  • 31. Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.
    Richards JR.
    Biologicals; 2005 Dec 15; 33(4):215-7. PubMed ID: 16257536
    [Abstract] [Full Text] [Related]

  • 32. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
    Boretti FS, Leutenegger CM, Mislin C, Hofmann-Lehmann R, König S, Schroff M, Junghans C, Fehr D, Huettner SW, Habel A, Flynn JN, Aubert A, Pedersen NC, Wittig B, Lutz H.
    AIDS; 2000 Aug 18; 14(12):1749-57. PubMed ID: 10985311
    [Abstract] [Full Text] [Related]

  • 33. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN, Beatty JA, Cannon CA, Stephens EB, Hosie MJ, Neil JC, Jarrett O.
    AIDS Res Hum Retroviruses; 1995 Sep 18; 11(9):1107-13. PubMed ID: 8554908
    [Abstract] [Full Text] [Related]

  • 34. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax® FIV).
    Westman M, Yang D, Green J, Norris J, Malik R, Parr YA, McDonald M, Hosie MJ, VandeWoude S, Miller C.
    Viruses; 2021 Mar 12; 13(3):. PubMed ID: 33809232
    [Abstract] [Full Text] [Related]

  • 35. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC, Pu R, Pollock D, Vitsky A, Tartaglia J, Paoletti E, Yamamoto JK.
    AIDS; 1998 Jan 01; 12(1):11-8. PubMed ID: 9456250
    [Abstract] [Full Text] [Related]

  • 36. [Diagnosis of FIV infection].
    Hartmann K, Kuffer M, Egberink H, Lutz H, Kraft W.
    Tierarztl Prax; 1994 Jun 01; 22(3):268-72. PubMed ID: 8048037
    [Abstract] [Full Text] [Related]

  • 37. Retrospective serologic survey for the presence of feline immunodeficiency virus antibody: a comparison of ELISA and IFA techniques.
    Reid RW, Barr MC, Scott FW.
    Cornell Vet; 1992 Oct 01; 82(4):359-69. PubMed ID: 1330430
    [Abstract] [Full Text] [Related]

  • 38. The variability of serological and molecular diagnosis of feline immunodeficiency virus infection.
    Bienzle D, Reggeti F, Wen X, Little S, Hobson J, Kruth S.
    Can Vet J; 2004 Sep 01; 45(9):753-7. PubMed ID: 15510684
    [No Abstract] [Full Text] [Related]

  • 39. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
    Huisman W, Karlas JA, Siebelink KH, Huisman RC, de Ronde A, Francis MJ, Rimmelzwaan GF, Osterhaus AD.
    Vaccine; 1998 Sep 01; 16(2-3):181-7. PubMed ID: 9607028
    [Abstract] [Full Text] [Related]

  • 40. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S, Leutenegger CM, Dean GA, Steckbeck JD, Cole KS, Sparger EE.
    J Virol; 2007 Jan 01; 81(2):465-73. PubMed ID: 17079309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.